Table 2B groups the genes RAS (KRAS and NRAS) and BRAF, (which are expressed as signalling molecules in the mitogen-activated protein kinase pathway (MAPK)) in relation to their use as prognostic/predictive MBMs in CRC. This evidence concerns the gene KRAS and colorectal carcinoma.